John Overdeck’s Opus Genetics IRD Stock Holding History

John Overdeck’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	253,962 +145,321	+134%	+$678K	﹤0.01%	3585
2026 Q1	$494K	Sell	108,641 -42,671	-28%	-$148K	﹤0.01%	3754
2025 Q4	$304K	Buy	151,312 +42,974	+40%	+$87.2K	﹤0.01%	3564
2025 Q3	$179K	Buy	108,338 +68,148	+170%	+$84.7K	﹤0.01%	3394
2025 Q2	$37.9K	Buy	+40,190	New	+$37.2K	﹤0.01%	3088
2023 Q3	–	Sell	-19,086	Closed	-$82.8K	–	3264
2023 Q2	$82.8K	Buy	+19,086	New	+$90.6K	﹤0.01%	2776
2022 Q2	–	Sell	-51,700	Closed	-$168K	–	3017
2022 Q1	$168K	Sell	51,700 -68,200	-57%	-$233K	﹤0.01%	2363
2021 Q4	$447K	Buy	119,900 +83,017	+225%	+$333K	﹤0.01%	3356
2021 Q3	$190K	Buy	+36,883	New	+$170K	﹤0.01%	3978
2014 Q3	–	Sell	-39	Closed	-$16K	–	2103
2014 Q2	$16K	Buy	+39	New	+$17.7K	﹤0.01%	2109

Other funds holding IRD

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

John Overdeck's IRD Position: Q2 2026 in Review

John Overdeck increased its Opus Genetics (IRD) stake by 134% in Q2 2026, buying an estimated $678K and bringing the position to 253,962 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3585.

John Overdeck first reported a position in IRD in Q2 2014 and has held it in 10 quarters since. 102 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

John Overdeck held 253,962 shares of Opus Genetics worth $1.04M as of Q2 2026.
John Overdeck bought 145,321 Opus Genetics shares in Q2 2026, an estimated $678K.
Opus Genetics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3585 holding.
John Overdeck first reported a position in Opus Genetics in Q2 2014 and has held it in 10 quarters since.
102 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.